Shopping Cart 0
Cart Subtotal
USD 0

Omega Pharma NV - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Summary

Omega Pharma NV (Omega Pharma), a subsidiary of Perrigo Company plc, is a pharmaceutical company focusing on the development, manufacture and sale of prescription-free or Over the Counter (OTC) health and personal care products. The company's product portfolio includes cough and cold products, skin care products, pain relief products, vitamins, minerals, and nutritional supplements. Its products cater to gastro-intestinal disorders, respiratory issues, eye care, weight management, food supplements, baby care, and skin care. Besides, the company offers auto-diagnostic products such as body temperature meters, ovulation meters and blood pressure meters. It distributes these products to customers through retail distribution and drug store chains. Omega Pharma is headquartered in Nazareth, Belgium.

Omega Pharma NV-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Omega Pharma NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Omega Pharma NV, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Omega Pharma Acquires Arterin Business Of Pharco For USD 13 Million 11

Omega Pharma Acquires Rights To Optalidon From Novartis Consumer Health 13

Omega Pharma Completes Acquisition Of Identified Non-Core OTC Brands In Europe From GSK For USD 614 Million 14

Partnerships 16

Dompe Farmaceutici Enters into Distribution Agreement with Omega Pharma 16

NovaMedica Enters into Co-Marketing Agreement with Omega Pharma 17

Omega Pharma Enters Into Co-Marketing Agreement With Kwizda Pharma For BronchoStop Cough Products 18

Omega Pharma Enters Into Joint Venture With Cavi Brands To Form OmegaLabs 19

Omega Pharma Enters Into Co-Development Agreement With Sienna Biotec 20

Licensing Agreements 21

Hikma Pharma Enters into Licensing Agreement with Omega Pharma Trading 21

BioLineRx Enters into Licensing Agreement with Omega Pharma for BL-5010 22

Equity Offering 23

Omega Pharma Completes Public Offering Of Shares For USD 237 Million 23

Debt Offering 24

Omega Pharma Completes Public Offering Of Bonds Due 2017 For USD 383 Million 24

Omega Pharma Completes Public Offering Of Bonds Due 2017 For USD 237.6 Million 25

Omega Pharma Completes Public Offering Of Bonds Due 2019 For USD 158.4 Million 26

Acquisition 27

Perrigo Acquires Omega Pharma for USD4.76 Billion 27

Omega Pharma Acquires Naturoteek 29

Couckinvest Completes Acquisition Of Remaining Stake In Omega Pharma For USD 1.26 Billion 30

Omega Pharma NV-Key Competitors 32

Omega Pharma NV-Key Employees 33

Omega Pharma NV-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Joint Venture 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Omega Pharma NV, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Omega Pharma NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Omega Pharma NV, Deals By Therapy Area, 2012 to YTD 2018 8

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Omega Pharma Acquires Arterin Business Of Pharco For USD 13 Million 11

Omega Pharma Acquires Rights To Optalidon From Novartis Consumer Health 13

Omega Pharma Completes Acquisition Of Identified Non-Core OTC Brands In Europe From GSK For USD 614 Million 14

Dompe Farmaceutici Enters into Distribution Agreement with Omega Pharma 16

NovaMedica Enters into Co-Marketing Agreement with Omega Pharma 17

Omega Pharma Enters Into Co-Marketing Agreement With Kwizda Pharma For BronchoStop Cough Products 18

Omega Pharma Enters Into Joint Venture With Cavi Brands To Form OmegaLabs 19

Omega Pharma Enters Into Co-Development Agreement With Sienna Biotec 20

Hikma Pharma Enters into Licensing Agreement with Omega Pharma Trading 21

BioLineRx Enters into Licensing Agreement with Omega Pharma for BL-5010 22

Omega Pharma Completes Public Offering Of Shares For USD 237 Million 23

Omega Pharma Completes Public Offering Of Bonds Due 2017 For USD 383 Million 24

Omega Pharma Completes Public Offering Of Bonds Due 2017 For USD 237.6 Million 25

Omega Pharma Completes Public Offering Of Bonds Due 2019 For USD 158.4 Million 26

Perrigo Acquires Omega Pharma for USD4.76 Billion 27

Omega Pharma Acquires Naturoteek 29

Couckinvest Completes Acquisition Of Remaining Stake In Omega Pharma For USD 1.26 Billion 30

Omega Pharma NV, Key Competitors 32

Omega Pharma NV, Key Employees 33

Omega Pharma NV, Subsidiaries 34

Omega Pharma NV, Joint Venture 35

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Summary

Omega Pharma NV (Omega Pharma), a subsidiary of Perrigo Company plc, is a pharmaceutical company focusing on the development, manufacture and sale of prescription-free or Over the Counter (OTC) health and personal care products. The company's product portfolio includes cough and cold products, skin care products, pain relief products, vitamins, minerals, and nutritional supplements. Its products cater to gastro-intestinal disorders, respiratory issues, eye care, weight management, food supplements, baby care, and skin care. Besides, the company offers auto-diagnostic products such as body temperature meters, ovulation meters and blood pressure meters. It distributes these products to customers through retail distribution and drug store chains. Omega Pharma is headquartered in Nazareth, Belgium.

Omega Pharma NV-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Omega Pharma NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Omega Pharma NV, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Omega Pharma Acquires Arterin Business Of Pharco For USD 13 Million 11

Omega Pharma Acquires Rights To Optalidon From Novartis Consumer Health 13

Omega Pharma Completes Acquisition Of Identified Non-Core OTC Brands In Europe From GSK For USD 614 Million 14

Partnerships 16

Dompe Farmaceutici Enters into Distribution Agreement with Omega Pharma 16

NovaMedica Enters into Co-Marketing Agreement with Omega Pharma 17

Omega Pharma Enters Into Co-Marketing Agreement With Kwizda Pharma For BronchoStop Cough Products 18

Omega Pharma Enters Into Joint Venture With Cavi Brands To Form OmegaLabs 19

Omega Pharma Enters Into Co-Development Agreement With Sienna Biotec 20

Licensing Agreements 21

Hikma Pharma Enters into Licensing Agreement with Omega Pharma Trading 21

BioLineRx Enters into Licensing Agreement with Omega Pharma for BL-5010 22

Equity Offering 23

Omega Pharma Completes Public Offering Of Shares For USD 237 Million 23

Debt Offering 24

Omega Pharma Completes Public Offering Of Bonds Due 2017 For USD 383 Million 24

Omega Pharma Completes Public Offering Of Bonds Due 2017 For USD 237.6 Million 25

Omega Pharma Completes Public Offering Of Bonds Due 2019 For USD 158.4 Million 26

Acquisition 27

Perrigo Acquires Omega Pharma for USD4.76 Billion 27

Omega Pharma Acquires Naturoteek 29

Couckinvest Completes Acquisition Of Remaining Stake In Omega Pharma For USD 1.26 Billion 30

Omega Pharma NV-Key Competitors 32

Omega Pharma NV-Key Employees 33

Omega Pharma NV-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Joint Venture 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36


List Of Figure

List of Figures

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Omega Pharma NV, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Omega Pharma NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Omega Pharma NV, Deals By Therapy Area, 2012 to YTD 2018 8

Omega Pharma NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Omega Pharma Acquires Arterin Business Of Pharco For USD 13 Million 11

Omega Pharma Acquires Rights To Optalidon From Novartis Consumer Health 13

Omega Pharma Completes Acquisition Of Identified Non-Core OTC Brands In Europe From GSK For USD 614 Million 14

Dompe Farmaceutici Enters into Distribution Agreement with Omega Pharma 16

NovaMedica Enters into Co-Marketing Agreement with Omega Pharma 17

Omega Pharma Enters Into Co-Marketing Agreement With Kwizda Pharma For BronchoStop Cough Products 18

Omega Pharma Enters Into Joint Venture With Cavi Brands To Form OmegaLabs 19

Omega Pharma Enters Into Co-Development Agreement With Sienna Biotec 20

Hikma Pharma Enters into Licensing Agreement with Omega Pharma Trading 21

BioLineRx Enters into Licensing Agreement with Omega Pharma for BL-5010 22

Omega Pharma Completes Public Offering Of Shares For USD 237 Million 23

Omega Pharma Completes Public Offering Of Bonds Due 2017 For USD 383 Million 24

Omega Pharma Completes Public Offering Of Bonds Due 2017 For USD 237.6 Million 25

Omega Pharma Completes Public Offering Of Bonds Due 2019 For USD 158.4 Million 26

Perrigo Acquires Omega Pharma for USD4.76 Billion 27

Omega Pharma Acquires Naturoteek 29

Couckinvest Completes Acquisition Of Remaining Stake In Omega Pharma For USD 1.26 Billion 30

Omega Pharma NV, Key Competitors 32

Omega Pharma NV, Key Employees 33

Omega Pharma NV, Subsidiaries 34

Omega Pharma NV, Joint Venture 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com